Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
OPKO Health, Inc. (NASDAQ:OPK) Receives $1.55 Consensus Price Target from Analysts
01:29am, Tuesday, 14'th Apr 2026
Shares of OPKO Health, Inc. (NASDAQ: OPK - Get Free Report) have earned an average recommendation of "Hold" from the six research firms that are presently covering the stock, Marketbeat Ratings report
Reviewing PROCEPT BioRobotics (NASDAQ:PRCT) & OPKO Health (NASDAQ:OPK)
01:40am, Monday, 06'th Apr 2026
OPKO Health (NASDAQ: OPK - Get Free Report) and PROCEPT BioRobotics (NASDAQ: PRCT - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two
Analysts Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.03
01:32am, Friday, 20'th Mar 2026
OPKO Health, Inc. (NASDAQ: OPK - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat reports. One research analyst has
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
02:35pm, Thursday, 19'th Mar 2026
OPK rides on RAYALDEE strength and partnerships, but revenue decline, losses, and reliance on a single drug cloud its near-term outlook.
Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Hypertension Diagnostics (OTCMKTS:HDII)
01:44am, Monday, 16'th Mar 2026
OPKO Health (NASDAQ: OPK - Get Free Report) and Hypertension Diagnostics (OTCMKTS:HDII - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two business
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
01:50pm, Friday, 27'th Feb 2026
OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
08:00am, Friday, 27'th Feb 2026
MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 202
Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Sintx Technologies (NASDAQ:SINT)
01:59am, Friday, 27'th Feb 2026
OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two busines
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
08:57pm, Thursday, 26'th Feb 2026
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics
08:01pm, Thursday, 26'th Feb 2026
While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics com
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
07:46pm, Thursday, 26'th Feb 2026
OPKO Health (OPK) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.01 per share a year ago.
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
04:05pm, Thursday, 26'th Feb 2026
MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces fi
OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday
03:22am, Thursday, 19'th Feb 2026
OPKO Health (NASDAQ: OPK - Get Free Report) is projected to post its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect OPKO Health to post earnings of ($0.07) per sha
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
11:41am, Wednesday, 18'th Feb 2026
OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE's performance and strategic pa
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
08:00am, Thursday, 12'th Feb 2026
MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S
